CSPC Pharmaceutical Group Limited
CSPCY · OTC
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $7,570,931 | $6,777,199 | $8,370,714 | $11,979,646 |
| Short-Term Investments | $2,132,500 | $1,473,112 | $2,442,314 | $1,073,865 |
| Receivables | $9,438,969 | $9,938,393 | $11,912,707 | $10,128,537 |
| Inventory | $2,870,785 | $3,130,014 | $3,457,142 | $3,452,955 |
| Other Curr. Assets | $413,660 | $362,346 | $83,899 | -$104,129 |
| Total Curr. Assets | $22,610,088 | $21,888,144 | $26,453,688 | $26,744,945 |
| Property Plant & Equip (Net) | $13,630,517 | $13,079,000 | $12,234,731 | $12,225,661 |
| Goodwill | $234,904 | $234,904 | $234,792 | $234,208 |
| Intangibles | $2,655,352 | $2,609,506 | $2,238,955 | $2,198,549 |
| Long-Term Investments | $930,598 | $4,797,901 | $6,442,839 | $4,641,243 |
| Tax Assets | $203,302 | $250,297 | $216,763 | $186,223 |
| Other NC Assets | $5,737,593 | $1,529,239 | $50,667 | $50,645 |
| Total NC Assets | $23,392,266 | $22,500,847 | $21,419,922 | $19,537,225 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $46,002,354 | $44,388,991 | $47,873,610 | $46,145,127 |
| Liabilities | – | – | – | – |
| Payables | $2,287,643 | $2,613,000 | $3,228,933 | $2,841,739 |
| Short-Term Debt | $247,459 | $392,204 | $202,560 | $450,216 |
| Tax Payable | $240,278 | $334,231 | $0 | $378,326 |
| Deferred Revenue | $0 | $0 | $0 | $325,239 |
| Other Curr. Liab. | $1,378,894 | $945,857 | $250,062 | $169,664 |
| Total Curr. Liab. | $10,112,501 | $9,634,027 | $10,435,307 | $10,182,573 |
| LT Debt | $0 | $0 | $0 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $427,549 | $424,731 | $571,804 | $573,141 |
| Other NC Liab. | $439,678 | $407,808 | $350,580 | $56,962 |
| Total NC Liab. | $1,025,977 | $888,674 | $988,700 | $738,863 |
| Other Liabilities | $0 | $0 | $0 | $342,722 |
| Cap. Leases | $247,541 | $115,126 | $186,310 | $106,741 |
| Total Liabilities | $11,138,478 | $10,522,701 | $11,424,007 | $11,264,158 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $9,218 | $1,410,661 |
| Common Stock | $11,036,169 | $11,032,752 | $11,005,842 | $10,867,139 |
| Retained Earnings | $24,511,571 | $23,344,080 | $25,034,365 | $21,765,283 |
| AOCI | $0 | $0 | $0 | -$1,410,661 |
| Other Equity | -$2,202,635 | -$2,088,941 | -$1,128,561 | $413,764 |
| Total Equity | $33,249,629 | $32,264,695 | $34,834,421 | $33,104,892 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $1,614,247 | $1,601,595 | $1,620,604 | $1,809,430 |
| Total Liab. & Tot. Equity | $46,002,354 | $44,388,991 | $47,873,610 | $46,145,127 |
| Net Debt | -$7,323,472 | -$6,384,995 | -$8,168,154 | -$11,529,430 |